Honeywell Automation India Ltd said its second quarter net profit declined to Rs22.9 crore from Rs31.9 crore same period a year ago.
The company’s total revenues, including other operating revenues, increased to Rs335.93 crore from Rs294.78 crore for the quarter ended 30 June 2009.
On Friday, Honeywell Automation shares fell 6.6% to Rs2,818 on the Bombay Stock Exchange, while the Sensex ended at 0.3% up at 17,955 points.
Mumbai-based Supreme Industries Ltd said its first quarter net profit rose to Rs144.8 crore from Rs97.4 crore a year ago.
During the first quarter to end-June, its total revenues increased to Rs2,014.9 crore from Rs1,656 crore same period previous year, Supreme Industries said in a regulatory filing.
On Friday, Supreme Industries shares ended 1.7% down to Rs579 on the Bombay Stock Exchange, while the Sensex closed 0.3% up at 17,955 points.
Sun Pharmaceutical Industries Ltd said it received abbreviated new drug application (ANDA) approval from US Food and Drug Administration (USFDA) for generic version of Flomax, tamsulosin capsules to sell it in the US.
Tamsulosin hydrochloride capsules are used in the treatment of the benign prostatic hyperplasia (BPH). Tamsulosin hydrochloride capsules, 0.4 mg are therapeutically equivalent to Flomax capsules 0.4 mg from Boehringer Ingelheim Pharmaceuticals Inc.
On Friday, Sun Pharma shares closed 0.5% down at Rs1,739 on the Bombay Stock Exchange, while the Sensex ended at 0.3% up at 17,955 points.